Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePHASE 1B KEYNOTE‐013 STUDY OF PEMBROLIZUMAB IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: RESULTS OF >4 YEARS OF FOLLOW‐UP.AuthorsZinzani, P.L.; Armand, P.; Ribrag, V.; Michot, J.; Kuruvilla, J.; Zhu, Y.; Farooqui, M.; Nahar, A.; Moskowitz, C.H.SubjectsHODGKIN'S disease; FOLLOW-up studies (Medicine)PublicationHematological Oncology, 2019, Vol 37, p296ISSN0278-0232Publication typeArticleDOI10.1002/hon.106_2630